A

Aurinia Pharmaceuticals
D

AUPH

8.99500
USD
-0.05
(-0.50%)
مفتوح الان
حجم التداول
18,038
الربح لكل سهم
-0
العائد الربحي
-
P/E
-60
حجم السوق
1,287,897,525
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACAD
    0.210
    (1.24%)
    17.090 USD
    B
    BLUE
    -0.74000
    (-8.72%)
    7.75000 USD
    B
    BMRN
    0.440
    (0.67%)
    66.120 USD
    C
    CRSP
    -0.310
    (-0.76%)
    40.410 USD
    D
    DVAX
    0.150
    (1.18%)
    12.870 USD
    E
    EDIT
    -0.04500
    (-3.41%)
    1.27500 USD
    L
    LGND
    0.620
    (0.54%)
    115.420 USD
    R
    RARE
    -0.520
    (-1.18%)
    43.670 USD
    S
    SRPT
    0.650
    (0.55%)
    119.620 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
    المزيد
الأخبار
المقالات

العنوان: Aurinia Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.